カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/19 | 1,098 | 1,113 | 1,098 | 1,110 | +1 | +0.1% | 5,600 |
| 2023/01/18 | 1,098 | 1,109 | 1,092 | 1,109 | +17 | +1.6% | 4,700 |
| 2023/01/17 | 1,096 | 1,099 | 1,089 | 1,092 | -8 | -0.7% | 5,500 |
| 2023/01/16 | 1,098 | 1,100 | 1,091 | 1,100 | +3 | +0.3% | 12,700 |
| 2023/01/13 | 1,097 | 1,100 | 1,096 | 1,097 | -2 | -0.2% | 2,300 |
| 2023/01/12 | 1,117 | 1,117 | 1,099 | 1,099 | -7 | -0.6% | 4,400 |
| 2023/01/11 | 1,112 | 1,120 | 1,105 | 1,106 | -14 | -1.3% | 7,200 |
| 2023/01/10 | 1,107 | 1,122 | 1,107 | 1,120 | +18 | +1.6% | 15,600 |
| 2023/01/06 | 1,097 | 1,108 | 1,094 | 1,102 | +14 | +1.3% | 3,800 |
| 2023/01/05 | 1,105 | 1,105 | 1,087 | 1,088 | -7 | -0.6% | 6,200 |
| 2023/01/04 | 1,111 | 1,119 | 1,095 | 1,095 | -23 | -2.1% | 6,600 |
| 2022/12/30 | 1,101 | 1,125 | 1,092 | 1,118 | +18 | +1.6% | 11,400 |
| 2022/12/29 | 1,104 | 1,104 | 1,084 | 1,100 | -4 | -0.4% | 4,200 |
| 2022/12/28 | 1,091 | 1,107 | 1,086 | 1,104 | +13 | +1.2% | 9,700 |
| 2022/12/27 | 1,084 | 1,091 | 1,071 | 1,091 | +8 | +0.7% | 5,800 |
| 2022/12/26 | 1,073 | 1,083 | 1,060 | 1,083 | +12 | +1.1% | 8,600 |
| 2022/12/23 | 1,065 | 1,071 | 1,053 | 1,071 | +1 | +0.1% | 7,700 |
| 2022/12/22 | 1,064 | 1,070 | 1,052 | 1,070 | +5 | +0.5% | 5,700 |
| 2022/12/21 | 1,046 | 1,067 | 1,046 | 1,065 | +3 | +0.3% | 9,900 |
| 2022/12/20 | 1,088 | 1,096 | 1,048 | 1,062 | -26 | -2.4% | 15,600 |
| 2022/12/19 | 1,097 | 1,098 | 1,085 | 1,088 | -12 | -1.1% | 4,200 |
| 2022/12/16 | 1,087 | 1,103 | 1,085 | 1,100 | +8 | +0.7% | 10,200 |
| 2022/12/15 | 1,092 | 1,095 | 1,087 | 1,092 | ±0 | ±0% | 5,400 |
| 2022/12/14 | 1,093 | 1,093 | 1,084 | 1,092 | +8 | +0.7% | 2,900 |
| 2022/12/13 | 1,106 | 1,106 | 1,081 | 1,084 | -18 | -1.6% | 9,200 |
| 2022/12/12 | 1,101 | 1,105 | 1,101 | 1,102 | +1 | +0.1% | 1,700 |
| 2022/12/09 | 1,099 | 1,102 | 1,097 | 1,101 | +8 | +0.7% | 4,300 |
| 2022/12/08 | 1,090 | 1,095 | 1,086 | 1,093 | -6 | -0.5% | 2,500 |
| 2022/12/07 | 1,076 | 1,101 | 1,072 | 1,099 | +27 | +2.5% | 10,000 |
| 2022/12/06 | 1,074 | 1,083 | 1,068 | 1,072 | -9 | -0.8% | 7,200 |
| 2022/12/05 | 1,095 | 1,095 | 1,081 | 1,081 | -20 | -1.8% | 14,800 |
| 2022/12/02 | 1,116 | 1,116 | 1,101 | 1,101 | -15 | -1.3% | 6,900 |
| 2022/12/01 | 1,124 | 1,127 | 1,115 | 1,116 | -4 | -0.4% | 8,200 |
| 2022/11/30 | 1,119 | 1,120 | 1,113 | 1,120 | +4 | +0.4% | 2,700 |
| 2022/11/29 | 1,110 | 1,116 | 1,105 | 1,116 | +1 | +0.1% | 3,700 |
| 2022/11/28 | 1,118 | 1,122 | 1,112 | 1,115 | -4 | -0.4% | 8,500 |
| 2022/11/25 | 1,146 | 1,149 | 1,117 | 1,119 | -6 | -0.5% | 24,500 |
| 2022/11/24 | 1,159 | 1,159 | 1,125 | 1,125 | -14 | -1.2% | 26,400 |
| 2022/11/22 | 1,175 | 1,175 | 1,132 | 1,139 | -24 | -2.1% | 22,900 |
| 2022/11/21 | 1,170 | 1,180 | 1,156 | 1,163 | -2 | -0.2% | 20,200 |
| 2022/11/18 | 1,152 | 1,171 | 1,143 | 1,165 | +13 | +1.1% | 15,100 |
| 2022/11/17 | 1,134 | 1,152 | 1,130 | 1,152 | +16 | +1.4% | 17,600 |
| 2022/11/16 | 1,139 | 1,141 | 1,129 | 1,136 | -3 | -0.3% | 7,900 |
| 2022/11/15 | 1,143 | 1,146 | 1,130 | 1,139 | -1 | -0.1% | 12,900 |
| 2022/11/14 | 1,101 | 1,140 | 1,101 | 1,140 | +28 | +2.5% | 25,500 |
| 2022/11/11 | 1,098 | 1,112 | 1,088 | 1,112 | +26 | +2.4% | 11,200 |
| 2022/11/10 | 1,087 | 1,099 | 1,078 | 1,086 | -1 | -0.1% | 15,300 |
| 2022/11/09 | 1,110 | 1,111 | 1,086 | 1,087 | -17 | -1.5% | 14,300 |
| 2022/11/08 | 1,125 | 1,125 | 1,102 | 1,104 | -16 | -1.4% | 7,200 |
| 2022/11/07 | 1,090 | 1,120 | 1,090 | 1,120 | +39 | +3.6% | 15,700 |
551～
600
件表示中 / 3682件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 114,300円 | +6.8% | -13.8% | 3.06% | 8.76倍 | 0.75倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ティムス | 13,900円 | - | - | 0.00% | - | 2.01倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| ペルセウス | 38,000円 | +20.0% | - | 0.00% | - | 3.18倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| ＤＷＴＩ | 11,000円 | -15.1% | - | 0.00% | - | 6.80倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
| カルナバイオ | 25,200円 | +13.5% | - | 0.00% | - | 1.94倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
